Efficacy of sorafenib correlates with Memorial Sloan-Kettering Cancer Center (MSKCC) risk classification and bone metastasis in Chinese patients with metastatic renal cell carcinoma
Crossref DOI link: https://doi.org/10.1007/s13402-015-0245-5
Published Online: 2015-11-23
Published Print: 2016-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhang, Yushi
Li, Yongqiang
Cai, Yi
Wang, Ke
Li, Hanzhong
Text and Data Mining valid from 2015-11-23